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Introduction 
 
Histiocytic sarcoma complex (HSC) is commonly found in Bernese Mountain dogs (BMD). 
Peri-articular histiocytic sarcoma (PAHS) is a sub-entity of HSC. PAHS may be confused 
with synovial cell sarcoma (SCS) on histology. The hypothesis of this study is that 
PAHS/SCS in BMD will be more frequently encountered around previously diseased joints 
compared to normal joints.  
Methods 
 
Data were obtained through a European internet questionnaire 
(www.bmdhealthsurvey.eu), and medical records of two pathology labs. Statistical 
analysis was performed by Pearson Chi-square and Fisher Exact tests. Effect Size was 
analyzed by Nagelkerke R2. 4 PAHS and 4 SCS were immunolabeled with CD18 and 
pancytokeratin in an attempt to differentiate these tumor types. 
Results 
 
All PAHS and SCS stained positive for CD18 and negative for pancytokeratin. 660 
European BMD were included in the study. 158 dogs had previous joint disease, of whom 
13 developed PAHS/SCS around a previously diseased joint; 3 dogs had PAHS/SCS in 
another joint. Of the 502 BMD without joint disease, 8 developed PAHS/SCS. A 
significant association between previous joint disease and PAHS/SCS of the same joint 
was demonstrated for the left elbow (p=0.018), and left and right stifle (p<0.001), with 
Effect Sizes of 0.174, 0.231, and 0.227 respectively.  
Conclusions 
Significant association with reasonably high Effect Sizes indicate a causal relation of 
previous joint disease and the development of PAHS/SCS in the same joint of European 
BMD, although the power of the statistical analysis is low due to the small sample size. 
CD18 and pancytokeratin staining was not able to differentiate PAHS from SCS. 
 
